Expression of TIE-1 kinase in gastric cancer patients is associated with reduced survival rates, and it is an independent factor affecting gastric cancer patient survival (Ref. 37).
However, the strongest expression of Tie-2 was seen in vascular 'hot spots' within the inflammatory infiltrate at the periphery of invasive tumours.
The next step in differentiation is the first stage of HE development which is defined by the expression of Tie-2 and c-kit, and a low level of Runx1 mRNA.
Expression of Tie-1 has been reported in breast, gastric, colon, and thyroid cancers, but constitutive activation has only been proven in a breast cancer cell line [ 40, 41].
When semi-confluent HBMEC were exposed to OGD for 24 h, increased gene expression of Tie-2 (2.5 fold), MCP-1 (11.4 fold) and MMP-2 (2.1 fold) were obtained by real-time PCR.
Furthermore, HSCs can regulate the level of hypoxia-inducible factor-1 α, accompanied by the increased expression of Tie-1 and vascular endothelial growth factor, which adjusts the O2 gradient to promote HSC homing to the niche.
The expression of Tie-1 and Tie-2 has been reported in the RA synovium, and there is significant upregulation of Tie-1 on endothelial cells, on lining cells and on macrophages in RA compared with normal [ 87- 89].
Until recently, expression of Tie-2 was thought to be restricted to endothelial cells, but in 2005 De Palma and colleagues showed that a subpopulation of murine blood monocytes expressing Tie-2 are recruited into spontaneous murine and orthotopic human xenograft tumours and have a crucial role in stimulating tumour angiogenesis [ 27].
Moreover, the downregulation of VEGF-B and -D was also reported in response to paclitaxel treatment in ovarian carcinoma xenografts, whereas the expressions of Tie-1 and Tie-2 were significantly upregulated.
Ang-1 is expressed by myeloma cells and is associated with upregulated expression of Tie-2 on bone marrow endothelial cells and increased vascularisation in vivo.
Finally, co-labeling of Tie-2 with CD34 demonstrated that expression of the Tie-2 receptor is colocalized to the endothelium of the developing vasculature during early development but shifts to the large vessels associated with central airways in late development, although some expression remains in the mesenchyme (Fig. 4A C).
